Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E C Cole

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Epidemiology (Cambridge, Mass.)|May 3, 2007
Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified populationJoel G Ray, Philip R Wyatt, Miles D Thompson, et al.
The Journal of Clinical Endocrinology and Metabolism|May 25, 2006
Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillanceVito Guarnieri, Alfredo Scillitani, Lucia Anna Muscarella, et al.
Molecular Diagnosis & Therapy|December 13, 2006
G-protein-coupled receptors and asthma endophenotypes: the cysteinyl leukotriene system in perspectiveMiles D Thompson, Jun Takasaki, Valérie Capra, et al.
Clinical Biochemistry|February 27, 2007
Genetic variation at the calcium-sensing receptor (CASR) locus: implications for clinical molecular diagnosticsFrancisco H J Yun, Betty Y L Wong, Maretta Chase, et al.
The Journal of Clinical Endocrinology and Metabolism|May 21, 2015
Cinacalcet Treatment in an Adolescent With Concurrent 22q11.2 Deletion Syndrome and Familial Hypocalciuric Hypercalcemia Type 3 Caused by AP2S1 MutationSirpa Tenhola, Geoffrey N Hendy, Helena Valta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2006
Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapyMark J Clemons, George Dranitsaris, Wei S Ooi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 13, 2002
Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemiaLilia D'Souza-Li, Bing Yang, Lucie Canaff, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2004
Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptorAlfredo Scillitani, Vito Guarnieri, Simona De Geronimo, et al.
BMC Pregnancy and Childbirth|September 21, 2007
Metabolic syndrome features and risk of neural tube defectsJoel G Ray, Miles D Thompson, Marian J Vermeulen, et al.
European Journal of Pediatrics|December 8, 2004
Mucolipidosis II presenting as severe neonatal hyperparathyroidismSheila Unger, David A Paul, Michelle C Nino, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Epidemiology (Cambridge, Mass.)|May 3, 2007
Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified populationJoel G Ray, Philip R Wyatt, Miles D Thompson, et al.
The Journal of Clinical Endocrinology and Metabolism|May 25, 2006
Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillanceVito Guarnieri, Alfredo Scillitani, Lucia Anna Muscarella, et al.
Molecular Diagnosis & Therapy|December 13, 2006
G-protein-coupled receptors and asthma endophenotypes: the cysteinyl leukotriene system in perspectiveMiles D Thompson, Jun Takasaki, Valérie Capra, et al.
Clinical Biochemistry|February 27, 2007
Genetic variation at the calcium-sensing receptor (CASR) locus: implications for clinical molecular diagnosticsFrancisco H J Yun, Betty Y L Wong, Maretta Chase, et al.
The Journal of Clinical Endocrinology and Metabolism|May 21, 2015
Cinacalcet Treatment in an Adolescent With Concurrent 22q11.2 Deletion Syndrome and Familial Hypocalciuric Hypercalcemia Type 3 Caused by AP2S1 MutationSirpa Tenhola, Geoffrey N Hendy, Helena Valta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2006
Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapyMark J Clemons, George Dranitsaris, Wei S Ooi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 13, 2002
Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemiaLilia D'Souza-Li, Bing Yang, Lucie Canaff, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2004
Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptorAlfredo Scillitani, Vito Guarnieri, Simona De Geronimo, et al.
BMC Pregnancy and Childbirth|September 21, 2007
Metabolic syndrome features and risk of neural tube defectsJoel G Ray, Miles D Thompson, Marian J Vermeulen, et al.
European Journal of Pediatrics|December 8, 2004
Mucolipidosis II presenting as severe neonatal hyperparathyroidismSheila Unger, David A Paul, Michelle C Nino, et al.
Pageof 12